Learn more Dave Denton, Pfizer's chief financial officer, is departing the pharmaceutical company for a position in consumer ...

Pfizer’s recent drug approvals give the company something to build on, with shareholders looking for evidence that cost cuts ...

Pfizer said on Thursday that finance chief Dave Denton will leave on August 15 to return to the consumer goods industry.

Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and ...

Pfizer Inc. (NYSE: PFE) today announced that Dave Denton, Chief Financial Officer, will step down from his current role and leave the company on August 15 for a professional opportunity outside of the ...

Pfizer's business may be in better shape than investors think.

Pfizer (PFE) stock drops 3% as CFO Dave Denton reveals August exit. Cecile Guegan appointed interim CFO while company ...

In the latest trading session, Pfizer (PFE) closed at $25.22, marking a -2.72% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 1.09% for the day. At the ...

Market Catalyst Host Julie Hyman breaks down today's Trending Tickers, giving us the latest on Accenture (ACN), Pfizer (PFE), ...

Pfizer (NYSE:PFE | PFE Price Prediction) trades at $25.62, pays a 6.7% dividend yield, and just posted five straight ...

Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and entertainment news.

Pfizer (PFE) shares dropped 3% following CFO Dave Denton's departure announcement. Cecile Guegan will serve as interim CFO ...